EHR

Medicat Makes Immunization Compliance Easier at Leading Universities

ATLANTA, Sept. 25, 2024 /PRNewswire/ -- Medicat, the #1 provider of Electronic Health Records (EHR) software for colleges and universities,…

3 months ago

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Reflects Growing Commitment to Renewable Energy Sources Energize virtual power purchase agreement will provide the equivalent of 25GWh of renewable energy…

3 months ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024…

3 months ago

Healthcare Software As A Service Market Surges to USD 68.5 Billion by 2030, Propelled by 10.7% CAGR – Verified Market Reports®

The Healthcare Software as a Service (SaaS) market is primarily driven by the increasing demand for cost-effective and scalable solutions…

3 months ago

Nabla Joins athenahealth’s Marketplace Program to expand access to AI-powered clinical documentation and promote clinician well-being

Nabla will automatically populate key sections of athenahealth, such as History of Present Illness, Physical Exam, Assessment & Plan, Social…

3 months ago

Community, Critical Access Hospitals Select Oracle Health CommunityWorks to Enhance Clinical and Financial Operations

New integrations extend the value of CommunityWorks with AI, data exchange, and patient accounting capabilities AUSTIN, Texas, Sept. 24, 2024…

3 months ago

InteliChart Enters New Agreement with Office Practicum to Amplify Patient Engagement for Pediatric Practices

Enhanced benefits and award-winning patient engagement solutions for pediatric practices. CHARLOTTE, N.C., Sept. 24, 2024 /PRNewswire/ -- InteliChart, an award-winning…

3 months ago

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413 is a bi-specific antibody…

3 months ago

Immutep Receives A$3.6 million R&D Tax Incentive from French Government

Media Release SYDNEY, AUSTRALIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”),…

3 months ago

electroCore Engages FNK IR to Execute Expanded Investor Relations Program

ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced…

3 months ago